Featured readings on methods and processes in HTA


Share this...
Tweet about this on TwitterShare on FacebookShare on LinkedInEmail this to someoneShare on Google+Share on RedditPin on Pinterest
Real-World Evidence

Louis P Garrison, Peter J. Neumann, Pennifer Erickson, Deborah Marshall, C. Daniel Mullins (2007) Using Real World Data for Coverage and Payment Decisions: the ISPOR Real World Data Task Force Report, Value in Health 10(5), p. 326-335, pdf, doi:10.1111/j.1524-4733.2007.00186.x

 

Health Technology Assessment

Michael F Drummond, J Sanford Schwartz, Bengt Jönsson, Bryan R Luce, Peter J Neumann, Uwe Siebert, Sean D Sullivan (2008) Key principles for the improved conduct of health technology assessments for resource allocation decisions., International journal of technology assessment in health care 24(3), p. 244-58; discussion 362-8, pubmed, doi:10.1017/S0266462308080343

Peter J. Neumann (2009) Lessons for health technology assessment: It is not only about the evidence, Value in Health 12(SUPPL. 2), pdf, doi:10.1111/j.1524-4733.2009.00558.x

John C. O'Donnell, Sissi V. Pham, Chris L. Pashos, David W. Miller, Marilyn Dix Smith (2009) Health technology assessment: Lessons learned from around the world - An overview, Value in Health 12(SUPPL. 2), p. S1-S5, url, doi:10.1111/j.1524-4733.2009.00550.x

Claude Le Pen (2009) Is there a "continental" view of health economics evaluation?, European Journal of Health Economics 10(2), p. 121-123, pdf, doi:10.1007/s10198-008-0141-2

Michael Drummond, Bengt Jönsson, Frans Rutten, Tom Stargardt (2011) Reimbursement of pharmaceuticals: Reference pricing versus health technology assessment, European Journal of Health Economics 12(3), p. 263-271, pdf, doi:10.1007/s10198-010-0274-y

 

Evidence-Based Medicine and Comparative Effectiveness Research

D. L Sackett, W. M C Rosenberg, J A M. Gray, R B. Haynes, W S. Richardson (1996) Evidence based medicine: what it is and what it isn't, Bmj 312(7023), p. 71-72, url, doi:10.1136/bmj.312.7023.71

David M. Eddy (2005) Evidence-based medicine: A unified approach, Health Affairs 24(1), p. 9-17, url, doi:10.1377/hlthaff.24.1.9

Milton C. Weinstein, George Torrance, Alistair McGuire (2009) QALYs: The basics, Value in Health 12(SUPPL. 1), pdf, doi:10.1111/j.1524-4733.2009.00515.x

David Eddy (2009) Health technology assessment and evidence-based medicine: What are we talking about?, Value in Health 12(SUPPL. 2), pdf, doi:10.1111/j.1524-4733.2009.00551.x

 

QALYs

Milton C. Weinstein, George Torrance, Alistair McGuire (2009) QALYs: The basics, Value in Health 12(SUPPL. 1), pdf, doi:10.1111/j.1524-4733.2009.00515.x

Erik Nord, Norman Daniels, Mark Kamlet (2009) QALYs: Some challenges, Value in Health 12(SUPPL. 1), url, doi:10.1111/j.1524-4733.2009.00516.x

Paul Kind, Jennifer Elston Lafata, Karl Matuszewski, Dennis Raisch (2009) The use of QALYs in clinical and patient decision-making: Issues and prospects, Value in Health 12(SUPPL. 1), p. S27-S30, url, doi:10.1111/j.1524-4733.2009.00519.x

 

Observational studies

Louis P. Garrison, Peter J. Neumann, Pennifer Erickson, Deborah Marshall, C. Daniel Mullins (2007) Using real-world data for coverage and payment decisions: The ISPOR real-world data Task Force report, Value in Health 10(5), p. 326-335, url, doi:10.1111/j.1524-4733.2007.00186.x

Marc L. Berger, Muhammad Mamdani, David Atkins, Michael L. Johnson (2009) Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force , Value in Health 12(8), p. 1044-1052, url, doi:10.1111/j.1524-4733.2009.00600.x

Emily Cox, Bradley C Martin, Tjeerd Van Staa, Edeltraut Garbe, Uwe Siebert, Michael L Johnson (2009) Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outco, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 12(8), p. 1053-1061, url, doi:10.1111/j.1524-4733.2009.00601.x

 

Compliance

Dyfrig Hughes, Warren Cowell, Tamas Koncz, Joyce Cramer (2007) Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations, Value in Health 10(6), p. 498-509, url, doi:10.1111/j.1524-4733.2007.00205.x

Joyce A. Cramer, Anuja Roy, Anita Burrell, Carol J. Fairchild, Mahesh J. Fuldeore, Daniel A. Ollendorf, Peter K. Wong (2008) Medication compliance and persistence: Terminology and definitions, Value in Health 11(1), p. 44-47, url, doi:10.1111/j.1524-4733.2007.00213.x